Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dietary supplements

Executive Summary

Could not be regulated by FDA as drugs solely on the basis of their potency or health claims, under legislation (HR 5746) introduced by Rep. Richardson (D-N.M.) on July 31. He describes the bill as a companion measure to Sen. Hatch's (R-Utah) S 2835 ("The Pink Sheet" June 29, T&G-12). Richardson also added an amendment to the FDA enforcement bill stating that the bill does not alter the law governing FDA's regulation of vitamins and minerals ("The Pink Sheet" July 13, T&G-4). In a July 31 floor statement, Richardson said "nearly every member" of Congress has received mail from constituents concerned about access to supplements.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021300

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel